$CMRX
CHIMERIX INC Stock $cmrx

$cmrx Overview Financials Valuation SEC Filings Company Website

2016 Q3 Form 10-Q Financial Statement

#000111748016000052 Filed on August 08, 2016

Income Statement

Concept	2016 Q3	2016 Q2	2015 Q2
Revenue	$653.0K	$1.841M	$4.143M
YoY Change	-71.25%	-55.56%	350.82%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$5.830M	$6.610M	$7.332M
YoY Change	-32.31%	-9.85%	65.77%
% of Gross Profit
Research & Development	$12.25M	$13.76M	$21.86M
YoY Change	-53.78%	-37.06%	170.14%
% of Gross Profit
Depreciation & Amortization	$250.0K	$260.0K	$150.0K
YoY Change	38.89%	73.33%	200.0%
% of Gross Profit
Operating Expenses	$18.07M	$20.37M	$29.09M
YoY Change	-48.39%	-30.0%	132.47%
Operating Profit	-$17.42M	-$18.53M	-$24.95M
YoY Change	-46.8%	-25.75%	115.17%
Interest Expense	$400.0K	$380.0K	$140.0K
YoY Change	33.33%	171.43%	-200.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$17.03M	-$18.15M	-$24.82M
YoY Change	-47.52%	-26.87%	111.59%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$17.03M	-$18.15M	-$24.82M
YoY Change	-47.53%	-26.87%	111.48%
Net Earnings / Revenue	-2607.2%	-985.77%	-598.96%
Basic Earnings Per Share
Diluted Earnings Per Share	-$368.3K	-$392.8K	-$589.8K
COMMON SHARES
Basic Shares Outstanding	46.21M shares	46.21M shares	41.32M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q3	2016 Q2	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$249.7M	$272.8M	$258.3M
YoY Change	13.09%	5.61%	28.76%
Cash & Equivalents	$49.36M	$32.06M	$127.8M
Short-Term Investments	$200.3M	$240.8M	$130.6M
Other Short-Term Assets	$4.300M	$4.800M	$8.700M
YoY Change	-47.56%	-44.83%	171.88%
Inventory
Prepaid Expenses
Receivables	$379.0K	$313.0K	$2.311M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$254.4M	$277.9M	$269.3M
YoY Change	10.83%	3.19%	31.88%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.048M	$3.020M	$1.996M
YoY Change	24.97%	51.3%	299.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$39.80M	$29.80M	$150.1M
YoY Change	-75.05%	-80.15%
Other Assets	$34.00K	$93.00K	$80.00K
YoY Change	-54.67%	16.25%
Total Long-Term Assets	$42.88M	$32.92M	$152.2M
YoY Change	-73.53%	-78.38%	30343.0%
TOTAL ASSETS
Total Short-Term Assets	$254.4M	$277.9M	$269.3M
Total Long-Term Assets	$42.88M	$32.92M	$152.2M
Total Assets	$297.3M	$310.8M	$421.5M
YoY Change	-24.07%	-26.26%	105.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.280M	$4.217M	$9.819M
YoY Change	-74.61%	-57.05%	216.74%
Accrued Expenses	$6.338M	$6.311M	$10.76M
YoY Change	-18.56%	-41.34%	198.83%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$1.500M
YoY Change			-73.21%
Total Short-Term Liabilities	$9.618M	$10.53M	$22.06M
YoY Change	-54.37%	-52.28%	80.83%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$100.0K
YoY Change		-100.0%	-93.33%
Other Long-Term Liabilities	$300.0K	$300.0K	$134.0K
YoY Change	35.75%	123.88%	-55.33%
Total Long-Term Liabilities	$300.0K	$300.0K	$134.0K
YoY Change	35.75%	123.88%	-92.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.618M	$10.53M	$22.06M
Total Long-Term Liabilities	$300.0K	$300.0K	$134.0K
Total Liabilities	$9.903M	$10.83M	$22.20M
YoY Change	-53.5%	-51.19%	58.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$400.8M	-$383.8M	-$269.1M
YoY Change	32.92%	42.62%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$287.4M	$300.0M	$399.3M
YoY Change
Total Liabilities & Shareholders Equity	$297.3M	$310.8M	$421.5M
YoY Change	-24.07%	-26.26%	105.91%

Cashflow Statement

Concept	2016 Q3	2016 Q2	2015 Q2
OPERATING ACTIVITIES
Net Income	-$17.03M	-$18.15M	-$24.82M
YoY Change	-47.53%	-26.87%	111.48%
Depreciation, Depletion And Amortization	$250.0K	$260.0K	$150.0K
YoY Change	38.89%	73.33%	200.0%
Cash From Operating Activities	-$12.93M	-$12.55M	-$23.02M
YoY Change	-48.13%	-45.48%	139.04%
INVESTING ACTIVITIES
Capital Expenditures	-$260.0K	-$270.0K	-$820.0K
YoY Change	-58.06%	-67.07%	530.77%
Acquisitions
YoY Change
Other Investing Activities	$30.08M	$17.36M	-$65.16M
YoY Change	-152.32%	-126.64%	247.33%
Cash From Investing Activities	$29.82M	$17.09M	-$65.98M
YoY Change	-151.32%	-125.9%	249.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	400.0K	20.00K	161.2M
YoY Change	-4100.0%	-99.99%	45.58%
NET CHANGE
Cash From Operating Activities	-12.93M	-12.55M	-23.02M
Cash From Investing Activities	29.82M	17.09M	-65.98M
Cash From Financing Activities	400.0K	20.00K	161.2M
Net Change In Cash	17.29M	4.560M	72.17M
YoY Change	-120.82%	-93.68%	-12.19%
FREE CASH FLOW
Cash From Operating Activities	-$12.93M	-$12.55M	-$23.02M
Capital Expenditures	-$260.0K	-$270.0K	-$820.0K
Free Cash Flow	-$12.67M	-$12.28M	-$22.20M
YoY Change	-47.88%	-44.68%	133.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	1003000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1445000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	152000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1000000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-4000	USD
CY2015Q4	cmrx	Accrued Development Liabilities AccruedDevelopmentLiabilities	3596000	USD
CY2016Q2	cmrx	Accrued Development Liabilities AccruedDevelopmentLiabilities	2956000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001117480
CY2016Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	46214895	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	CHIMERIX INC
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10458000	USD
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	4217000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2432000	USD
CY2016Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	313000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9721000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-783000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-747000	USD
CY2016Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6311000	USD
CY2015Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	2939000	USD
CY2016Q2	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	2373000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-764000	USD
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-269000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	675591000	USD
CY2016Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	684015000	USD
CY2015Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2801000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5203000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4324000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8239000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	49000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1200000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1300000	shares
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	800000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	600000	shares
CY2015Q4	us-gaap	Assets Assets	355992000	USD
CY2016Q2	us-gaap	Assets Assets	310804000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	228837000	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	277889000	USD
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	323769000	USD
CY2016Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	270557000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2000	USD
CY2016Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	168000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	766000	USD
CY2016Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	436000	USD
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	324533000	USD
CY2016Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	270825000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2016Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	766000	USD
CY2016Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	436000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	317521000	USD
CY2016Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	14161000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	766000	USD
CY2016Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	436000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	317521000	USD
CY2016Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	14161000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2016Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	0	USD
CY2015Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	199729000	USD
CY2016Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	240755000	USD
CY2016Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	29802000	USD
CY2016Q2	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	269443000	USD
CY2016Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	239641000	USD
CY2015Q4	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	180	securities
CY2016Q2	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	4	securities
CY2015Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	124040000	USD
CY2016Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	29802000	USD
CY2015Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	180	securities
CY2016Q2	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	4	securities
CY2015Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	0	securities
CY2016Q2	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	0	securities
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	128462000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	127776000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20605000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32060000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-686000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	11455000	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46162525	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46214895	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46162525	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46214895	shares
CY2015Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	46000	USD
CY2016Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	46000	USD
CY2015Q2	us-gaap	Contracts Revenue ContractsRevenue	2598000	USD
	us-gaap	Contracts Revenue ContractsRevenue	3833000	USD
CY2016Q2	us-gaap	Contracts Revenue ContractsRevenue	1841000	USD
	us-gaap	Contracts Revenue ContractsRevenue	3069000	USD
CY2015Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	354000	USD
CY2016Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	306000	USD
	us-gaap	Depreciation Depreciation	264000	USD
	us-gaap	Depreciation Depreciation	525000	USD
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.59
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.13
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.39
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.96
CY2015Q4	us-gaap	Fair Value Assumptions Exercise Price FairValueAssumptionsExercisePrice	1.54
CY2015Q4	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0
CY2015Q4	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P169D
CY2015Q4	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.75
CY2015Q4	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0044
CY2015Q4	us-gaap	Fair Value Inputs Discount For Lack Of Marketability FairValueInputsDiscountForLackOfMarketability	0.10
	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Period FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPeriod	P18M
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	1114000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7234000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13295000	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6607000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13531000	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6972000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-9667000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2205000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2134000	USD
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-15000	USD
	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-33000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5828000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1272000	USD
CY2015Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	136000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	199000	USD
CY2016Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	377000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	749000	USD
	us-gaap	Interest Paid Net InterestPaidNet	132000	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2015Q4	us-gaap	Liabilities Liabilities	20533000	USD
CY2016Q2	us-gaap	Liabilities Liabilities	10834000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	355992000	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	310804000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20179000	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	10528000	USD
CY2015Q2	us-gaap	Licenses Revenue LicensesRevenue	1545000	USD
	us-gaap	Licenses Revenue LicensesRevenue	1548000	USD
CY2016Q2	us-gaap	Licenses Revenue LicensesRevenue	0	USD
	us-gaap	Licenses Revenue LicensesRevenue	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	161868000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	185000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-120697000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	52457000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-41857000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-41187000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-24815000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-47080000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-18148000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-44408000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	29094000	USD
	us-gaap	Operating Expenses OperatingExpenses	52660000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	20366000	USD
	us-gaap	Operating Expenses OperatingExpenses	48226000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-24951000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-47279000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-18525000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-45157000	USD
CY2015Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	200000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	300000	USD
CY2016Q2	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	200000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	400000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3186000	USD
CY2016Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	982000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	70000	USD
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	93000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1144000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1769000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	75000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	496000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-23671000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-45311000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-18073000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-43912000	USD
CY2015Q2	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2016Q2	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	147086000	USD
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	26818000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	950000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	504000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	33669000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2016Q2	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6071000	USD
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4761000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	161880000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	461000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	33000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	60005000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	79779000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-68000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3045000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3020000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	2850000	USD
	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21860000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	39365000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13759000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	34695000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-339414000	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-383822000	USD
CY2015Q2	us-gaap	Revenues Revenues	4143000	USD
	us-gaap	Revenues Revenues	5381000	USD
CY2016Q2	us-gaap	Revenues Revenues	1841000	USD
	us-gaap	Revenues Revenues	3069000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5203000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8239000	USD
CY2016Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	0	shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	0	shares
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	335459000	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	299970000	USD
CY2016Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2015Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	42079716	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	41614494	shares
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	46214086	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	46199110	shares

Files In Submission

Name	View Source	Status
0001117480-16-000052-index-headers.html	Edgar Link	pending
0001117480-16-000052-index.html	Edgar Link	pending
0001117480-16-000052.txt	Edgar Link	pending
0001117480-16-000052-xbrl.zip	Edgar Link	pending
a20160630cmrx10-qdocument.htm	Edgar Link	pending
a20160630cmrxex-103.htm	Edgar Link	pending
a20160630cmrxex-311.htm	Edgar Link	pending
a20160630cmrxex-312.htm	Edgar Link	pending
a20160630cmrxex-321.htm	Edgar Link	pending
a20160630cmrxex-322.htm	Edgar Link	pending
cmrx-20160630.xml	Edgar Link	completed
cmrx-20160630.xsd	Edgar Link	pending
cmrx-20160630_cal.xml	Edgar Link	unprocessable
cmrx-20160630_def.xml	Edgar Link	unprocessable
cmrx-20160630_lab.xml	Edgar Link	unprocessable
cmrx-20160630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CMRX
CHIMERIX INC Stock $cmrx

2016 Q3 Form 10-Q Financial Statement

#000111748016000052 Filed on August 08, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMRX CHIMERIX INC Stock $cmrx

2016 Q3 Form 10-Q Financial Statement

#000111748016000052 Filed on August 08, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMRX
CHIMERIX INC Stock $cmrx